Business Description
Founded in 2009 and based in Suzhou, China, Ascentage Pharma is a clinical-stage biopharmaceutical company focused on developing treatments for cancer, chronic hepatitis B, and age-related conditions. The company has built a broad pipeline of investigational medicines that work by targeting specific proteins involved in tumor growth and cell survival, with several compounds currently advancing through clinical trials. Beyond drug development, Ascentage also engages in scientific research services, venture investment, and partnerships with pharmaceutical companies and research institutions worldwide.
